Literature DB >> 18691078

Neurofibrillary tangles and senile plaques in Alzheimer's brains are associated with reduced capillary expression of vascular endothelial growth factor and endothelial nitric oxide synthase.

John Provias1, Brian Jeynes.   

Abstract

There is significant evidence to suggest that a dysfunctional blood-brain barrier [BBB] may contribute to the pathogenesis of some Alzheimer's disease [AD] lesions. An indicator for this could be diminished capillary vascular endothelial growth factor [VEGF] and / or endothelial nitric oxide synthase [eNOS] activity in AD brains. Cortical samples were taken from the superior temporal and calcarine cortices of ten confirmed AD and ten non-demented comparison brains. Contiguous coronal sections were stained using immunohistochemistry techniques to stain for tau protein, beta-amyloid [Abeta] n-termini ([40 & 42]), VEGF and eNOS. Standardized regions of cortex were randomly selected. Areas of ten contiguous field-diameters of comparable and full cortical widths were observed in each section and the densities of neurofibrillary tangles [NFTs], senile plaques [SPs] and Abeta, VEGF and eNOS positive capillaries were recorded. In both AD cortices there were significant inverse correlations found between both VEGF and eNOS-positive microvessels and the presence of NFTs, and each of the amyloid isoforms in SPs and amyloid-positive capillaries [p < 0.01]. In addition there was a significant positive correlation between VEGF and eNOS densities in both cortices [p< 0.01].These results suggest that diminished VEGF and eNOS activity in particularly lesion prone regions of AD brains may contribute to the pathogenesis of NFT and / or SP lesions.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18691078     DOI: 10.2174/156720208785425729

Source DB:  PubMed          Journal:  Curr Neurovasc Res        ISSN: 1567-2026            Impact factor:   1.990


  9 in total

1.  Ellagic acid prevents dementia through modulation of PI3-kinase-endothelial nitric oxide synthase signalling in streptozotocin-treated rats.

Authors:  Manish Kumar; Nitin Bansal
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2018-06-15       Impact factor: 3.000

2.  Partial Endothelial Nitric Oxide Synthase Deficiency Exacerbates Cognitive Deficit and Amyloid Pathology in the APPswe/PS1ΔE9 Mouse Model of Alzheimer's Disease.

Authors:  Sara Ahmed; Yu Jing; Bruce G Mockett; Hu Zhang; Wickliffe C Abraham; Ping Liu
Journal:  Int J Mol Sci       Date:  2022-06-30       Impact factor: 6.208

Review 3.  Vascular endothelial growth factor gene promoter polymorphisms and Alzheimer's disease risk: a meta-analysis.

Authors:  Sheng-Yuan Liu; Fang-Fang Zeng; Zhong-Wei Chen; Chang-Yi Wang; Bin Zhao; Ke-Shen Li
Journal:  CNS Neurosci Ther       Date:  2013-04-10       Impact factor: 5.243

Review 4.  Biological Hallmarks of Cancer in Alzheimer's Disease.

Authors:  Kelly N H Nudelman; Brenna C McDonald; Debomoy K Lahiri; Andrew J Saykin
Journal:  Mol Neurobiol       Date:  2019-04-16       Impact factor: 5.590

Review 5.  Blood-brain barrier leakage in Alzheimer's disease: From discovery to clinical relevance.

Authors:  Geetika Nehra; Bjoern Bauer; Anika M S Hartz
Journal:  Pharmacol Ther       Date:  2022-01-30       Impact factor: 13.400

Review 6.  Implications of Phosphoinositide 3-Kinase-Akt (PI3K-Akt) Pathway in the Pathogenesis of Alzheimer's Disease.

Authors:  Manish Kumar; Nitin Bansal
Journal:  Mol Neurobiol       Date:  2021-10-26       Impact factor: 5.682

7.  Platelets in the Alzheimer's disease brain: do they play a role in cerebral amyloid angiopathy?

Authors:  Kathrin M Kniewallner; Daniela Ehrlich; Andreas Kiefer; Josef Marksteiner; Christian Humpel
Journal:  Curr Neurovasc Res       Date:  2015       Impact factor: 1.990

8.  Altered plasma arginine metabolome precedes behavioural and brain arginine metabolomic profile changes in the APPswe/PS1ΔE9 mouse model of Alzheimer's disease.

Authors:  D H Bergin; Y Jing; B G Mockett; H Zhang; W C Abraham; P Liu
Journal:  Transl Psychiatry       Date:  2018-05-25       Impact factor: 6.222

9.  Altered expression of claudin family proteins in Alzheimer's disease and vascular dementia brains.

Authors:  Mihaela O Romanitan; Bogdan O Popescu; Stefan Spulber; Ovidiu Băjenaru; Laurenţiu M Popescu; Bengt Winblad; Nenad Bogdanovic
Journal:  J Cell Mol Med       Date:  2010-05       Impact factor: 5.310

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.